Jim Cramer breaks down drug stocks amid concerns over Zantac litigation

In this video

Share

Jim Cramer breaks down drug stocks amid concerns over Zantac litigation

'Mad Money' host Jim Cramer and the 'Squawk on the Street' team discuss pharma stocks that are trading lower amid alleged concerns that Sanofi and GSK's antacid drug Zantac causes cancer.
02:27
Thu, Aug 11 202210:34 AM EDT